secwatch.observer — SEC 8-K summary
======================================

Issuer:     FORUM MARKETS Inc (FRMM)
CIK:        0001690080
Form:       8-K
Filed at:   2023-12-15T23:59:59+00:00
Accession:  0001213900-23-095907
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq confirms 180 Life Sciences has regained compliance with Listing Rule 5635(d); matter closed
--------------------------------------------------------------------------------

- Received notice on December 14, 2023 that prior non-compliance with shareholder approval requirements is resolved.
- Company had violated Rule 5635(d) related to August 2023 offering of shares and warrants at below-market prices.
- Extension granted November 14, 2023 required completion of corrective actions by December 15, 2023.
- Actions included amending warrant terms to require stockholder approval before exercise.
- Nasdaq's notice confirms compliance and closure of the matter, removing delisting risk.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1690080/000121390023095907/0001213900-23-095907-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1690080/000121390023095907/ea190096-8k_180life.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-095907

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer